IHE — iShares U.S. Pharmaceuticals ETF
- Latest Close
- $86.02
- 30-Day Move
- +2.1%
- Shares Outstanding
- 11,600,000
iShares U.S. Pharmaceuticals ETF
A read-only Alphactor snapshot foriShares U.S. Pharmaceuticals ETF. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-24
Topline snapshot
Latest Close
$86.02
30-Day Move
+2.1%
Shares Outstanding
11,600,000
$86.02
+2.1%last 90 delayed daily bars
90D High
$92.30
90D Low
$83.03
Avg Volume
91,093
IHE is up 2.1% over the last 30 trading days shown on this page.
Latest Close
$86.02
30-Day Move
+2.1%
Shares Outstanding
11,600,000
Revenue
--
Gross Profit
--
Operating Income
--
Net Income
--
Gross Margin
--
Net Margin
--
Current Ratio
--
Debt / Equity
--
Altman Z
--
N/A
Piotroski
0
Insufficient data
Cash Conversion
--
Rule of 40
--
Insufficient data
Qube Research & Technologies
Filed 2025-08-14
--
--
Fisher Investments
Filed 2026-02-09
$240M
-2.1%
Goldman Sachs
Filed 2026-02-10
$7M
-43.1%
Citadel Advisors
Filed 2025-08-14
$3M
--
FMR LLC (Fidelity)
Filed 2026-02-17
$1M
+14.6%
Marshall Wace
Filed 2026-02-13
$1M
--
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.